Associate Professor Craig Munns

Staff Specialist - Endocrinology
Paediatrics & Child Health, Children's Hospital, Westmead

Telephone +61 2 9845 3200
Fax +61 2 9845 3170

Curriculum vitae Curriculum vitae

Map

Research interests

Improving the bone health, physical abilities and quality of life of children with musculoskeletal disorders through innovative diagnostics and therapies.

Current research students

Project title Research student
Bisphosphonate treatment in Perthes disease. Kamal MUHAMMAD ABDUL JAMIL

Keywords

Endocrinology; Osteoporosis; Bone health; Genetic diseases

Clinical Specialty

Paediatrics

Selected grants

2015

  • Clinical characteristics of children with generalized joint hypermobility - 3 year follow up; Nicholson L, Pacey V, Tofts L, Munns C; Arthritis Australia/Grants-in-Aid.

2013

  • Clinical Characteristics of Children with Generalised Joint Hypermobility; Nicholson L, Pacey V, Tofts L, Munns C; Arthritis Australia/Project Grants.

2010

  • Bisphosphonate Treatment of childhood femoral head avascular necrosis due to Perthes disease; Cowell C, Little D, Munns C, Foster B, Zacharin M; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Baseline Survey on the Oral Health of Children on IV Bisphosphonates.; Bhatt R, Blinkhorn A, Hibbert S, Munns C; Australian Dental Association Inc/Research Support.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Munns, C. (2013). Adolescent Bone Health. In Kate Steinbeck, Michael Kohn (Eds.), A Clinical Handbook in Adolescent Medicine: A Guide for Health Professionals Who Work with Adolescents and Young Adults, (pp. 479-490). Singapore: World Scientific Publishing.

Journals

  • Jefferson, A., Leonard, H., Siafarikas, A., Woodhead, H., Fyfe, S., Ward, L., Munns, C., Motil, K., Tarquinio, D., Shapiro, J., Ellaway, C., et al (2016). Clinical Guidelines for Management of Bone Health in Rett Syndrome Based on Expert Consensus and Available Evidence. PloS One, 11(2), 1-18. [More Information]
  • Munns, C., Shaw, N., Kiely, M., Specker, B., Thacher, T., Ozono, K., Michigami, T., Tiosano, D., Mughal, M., Makitie, O., et al (2016). Global Consensus Recommendations on Prevention and Management of Nutritional Rickets. Hormone Research in Paediatrics, 85(2), 83-106. [More Information]
  • Munns, C., Shaw, N., Kiely, M., Specker, B., Thacher, T., Osaka, K., Michigami, T., Tiosano, D., Mughal, M., Mäkitie, O., et al (2016). Global Consensus Recommendations on Prevention and Management of Nutritional Rickets. Journal of Clinical Endocrinology and Metabolism, 101(2), 394-415. [More Information]
  • Rushworth, L., Falhammar, H., Munns, C., Maguire, A., Torpy, D. (2016). Hospital Admission Patterns in Children with CAH: Admission Rates and Adrenal Crises Decline with Age. International Journal of Endocrinology, 2016 (Article number 5748264), 1-8. [More Information]
  • Padhye, B., Dalla-Pozza, L., Little, D., Munns, C. (2016). Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL). Cancer Medicine, 5(5), 960-967. [More Information]
  • Hsu, P., Ma, A., Barnes, E., Wilson, M., Hoefsloot, L., Rinne, T., Munns, C., Williams, G., Wong, M., Mehr, S. (2016). The Immune Phenotype of Patients with CHARGE Syndrome. The Journal of Allergy and Clinical Immunology: In Practice, 4(1), 96-103e.2. [More Information]
  • Bishop, N., Munns, C., Ozono, K. (2016). Transformative therapy in hypophosphatasia. Archives of Disease in Childhood, 101(6), 514-515. [More Information]
  • Korula, S., Titmuss, A., Biggin, A., Munns, C. (2015). A Practical Approach to Children with Recurrent Fractures. Endocrine Development, 28, 210-225. [More Information]
  • Brookes, D., Briody, J., Munns, C., Davies, P., Hill, R. (2015). Cystic fibrosis-related bone disease in children: Examination of peripheral quantitative computed tomography (pQCT) data. Journal of Cystic Fibrosis, 14(5), 668-677. [More Information]
  • Munns, C., Fahiminiya, S., Poudel, N., Munteanu, M., Majewski, J., Sillence, D., Metcalf, J., Biggin, A., Glorieux, F., Fassier, F., et al (2015). Homozygosity for Frameshift Mutations in XYLT2 Result in a Spondylo-Ocular Syndrome with Bone Fragility, Cataracts, and Hearing Defects. American Journal of Human Genetics, 96(6), 971-978. [More Information]
  • Pacey, V., Adams, R., Tofts, L., Munns, C., Nicholson, L. (2015). Joint hypermobility syndrome subclassification in paediatrics: A factor analytic approach. Archives of Disease in Childhood, 100(1), 8-13. [More Information]
  • Pacey, V., Tofts, L., Adams, R., Munns, C., Nicholson, L. (2015). Quality of life prediction in children with joint hypermobility syndrome. Journal of Paediatrics and Child Health, 51(7), 689-695. [More Information]
  • Biggin, A., Zheng, L., Briody, J., Coorey, C., Munns, C. (2015). The long-term effects of switching from active intravenous bisphosphonate treatment to low-dose maintenance therapy in children with osteogenesis imperfecta. Hormone Research in Paediatrics, 83(3), 183-189. [More Information]
  • Hsu, P., Ma, A., Wilson, M., Williams, G., Curotta, J., Munns, C., Mehr, S. (2014). CHARGE syndrome: A review. Journal of Paediatrics and Child Health, 50(7), 504-511. [More Information]
  • Brookes, D., Briody, J., Munns, C., Davies, P., Hill, R. (2014). Cystic fibrosis-related bone disease explored using a four step algorithm. Journal of Cystic Fibrosis, 14(1), 127-134. [More Information]
  • Bonnemann, C., Wang, C., Quijano-Roy, S., Deconinck, N., Bertini, E., Ferreiro, A., Muntoni, F., Sewry, C., Beroud, C., Mathews, K., et al (2014). Diagnostic approach to the congenital muscular dystrophies. Neuromuscular Disorders, 24(4), 289-311. [More Information]
  • Biggin, A., Briody, J., Ormshaw, E., Wong, K., Bennetts, B., Munns, C. (2014). Fracture during Intravenous Bisphosphonate Treatment in a Child with Osteogenesis Imperfecta: An Argument for a More Frequent, Low-Dose Treatment Regimen. Hormone Research in Paediatrics, 81(3), 204-210. [More Information]
  • Bishop, N., Arundel, P., Clark, E., Dimitri, P., Farr, J., Jones, G., Makitie, O., Munns, C., Shaw, N. (2014). Fracture Prediction and the Definition of Osteoporosis in Children and Adolescents: The ISCD 2013 Pediatric Official Positions. Journal of Clinical Densitometry: Assessment of Skeletal Health, 17(2), 275-280. [More Information]
  • Dasgupta, D., Wee, M., Reyes, M., Li, Y., Simm, P., Sharma, A., Schlingmann, K., Janner, M., Biggin, A., Lazier, J., Munns, C., et al (2014). Mutations in SLC34A3/NPT2c Are Associated with Kidney Stones and Nephrocalcinosis. Journal of the American Society of Nephrology, 25(10), 2366-2375. [More Information]
  • Biggin, A., Munns, C. (2014). Osteogenesis Imperfecta: Diagnosis and Treatment. Current Osteoporosis Reports, 12(3), 279-288. [More Information]
  • Pacey, V., Adams, R., Tofts, L., Munns, C., Nicholson, L. (2014). Proprioceptive acuity into knee hypermobile range in children with Joint Hypermobility Syndrome. Pediatric Rheumatology Online Journal, 12(1), 1-7. [More Information]
  • Nicholson, L., Pacey, V., Tofts, L., Munns, C., Adams, R. (2014). Signs and symptoms of foot and ankle dysfunction in children with joint hypermobility. Journal of Foot and Ankle Research, 7(Suppl 1).
  • Lazarus, S., McInerney-Leo, A., McKenzie, F., Baynam, G., Broley, S., Cavan, B., Munns, C., Pruijs, H., Sillence, D., Terhal, P., et al (2014). The IFITM5 mutation c.-14C > T results in an elongated transcript expressed in human bone; and causes varying phenotypic severity of osteogenesis imperfecta type V. BMC Musculoskeletal Disorders, 15(1), 1-6. [More Information]
  • Bhatt, R., Hibbert, S., Munns, C. (2014). The use of bisphosphonates in children: Review of the literature and guidelines for dental management. Australian Dental Journal, 59(1), 9-19. [More Information]
  • Bhatt, R., Hibbert, S., Munns, C. (2014). Use of bisphosphonates in children: authors' reply. Australian Dental Journal, 59(3), 405-406. [More Information]
  • Yap, C., Cheung, N., Gunton, J., Athayde, N., Munns, C., Duke, A., Mclean, M. (2014). Vitamin D Supplementation and the Effects on Glucose Metabolism During Pregnancy: A Randomized Controlled Trial. Diabetes Care, 37(7), 1837-1844. [More Information]
  • Biggin, A., Briody, J., Ramjan, K., Middleton, A., Waugh, M., Munns, C. (2013). Evaluation of bone mineral density and morphology using pQCT in children after spinal cord injury. Developmental Neurorehabilitation, 16(6), 391-397. [More Information]
  • Pacey, V., Tofts, L., Adams, R., Munns, C., Nicholson, L. (2013). Exercise in children with joint hypermobility syndrome and knee pain: a randomised controlled trial comparing exercise into hypermobile versus neutral knee extension. Pediatric Rheumatology Online Journal, 11(1), 1-11. [More Information]
  • Alcausin, M., Briody, J., Pacey, V., Ault, J., McQuade, M., Bridge, C., Engelbert, R., Sillence, D., Munns, C. (2013). Intravenous Pamidronate Treatment in Children with Moderate-to-Severe Osteogenesis Imperfecta Started under Three Years of Age. Hormone Research in Paediatrics, 79(6), 333-340. [More Information]
  • Ooi, H., Briody, J., Biggin, A., Cowell, C., Munns, C. (2013). Intravenous Zoledronic Acid Given Every 6 Months in Childhood Osteoporosis. Hormone Research in Paediatrics, 80(3), 179-184. [More Information]
  • Bishop, N., Adami, S., Ahmed, S., Anton, J., Arundel, P., Burren, C., Devogelaer, J., Hangartner, T., Hosszu, E., Munns, C., et al (2013). Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial. The Lancet, 382(9902), 1424-1432. [More Information]
  • O'Keefe, K., Orr, R., Huang, P., Selvadurai, H., Cooper, P., Munns, C., Fiatarone Singh, M. (2013). The effect of whole body vibration exposure on muscle function in children with cystic fibrosis: a pilot efficacy trial. Journal of Clinical Medicine Research, 5(3), 205-216. [More Information]
  • Rana, M., Munns, C., Selvadurai, H., Briody, J., Craig, M. (2013). The impact of dysglycaemia on bone mineral accrual in young people with cystic fibrosis. Clinical Endocrinology, 78(1), 36-42. [More Information]
  • Padhye, B., Dalla-Pozza, L., Little, D., Munns, C. (2013). Use of Zoledronic Acid for Treatment of Chemotherapy Related Osteonecrosis in Children and Adolescents: A Retrospective Analysis. Pediatric Blood & Cancer, 60(9), 1539-1545. [More Information]
  • Paxton, G., Teale, G., Nowson, C., Mason, R., McGrath, J., Thompson, M., Siafarikas, A., Rodda, C., Munns, C. (2013). Vitamin D and health in pregnancy, infants, children and adolescents in Australia and New Zealand: a position statement. Medical Journal of Australia, 198(3), 142-143. [More Information]
  • Wang, C., Dowling, J., North, K., Schroth, M., Sejersen, T., Shapiro, F., Bellini, J., Weiss, H., Guillet, M., Amburgey, K., Clarke, N., Fitzgerald, D., Munns, C., Rose, K., et al (2012). Consensus statement on standard of care for congenital myopathies. Journal of Child Neurology, 27(3), 363-382. [More Information]
  • Munns, C., Simm, P., Rodda, C., Garnett, S., Zacharin, M., Ward, L., Geddes, J., Cherain, S., Zurynski, Y., Cowell, C. (2012). Incidence of vitamin D deficiency rickets among Australian children: an Australian Paediatric Surveillance Unit study. Medical Journal of Australia, 196(7), 466-468. [More Information]
  • Cho, Y., Tchan, M., Roy, B., Halliday, R., Wilson, M., Dutt, S., Siew, S., Munns, C., Howard, N. (2012). Recombinant Parathyroid Hormone Therapy for Severe Neonatal Hypoparathyroidism. The Journal of Pediatrics, 160(2), 345-348. [More Information]
  • Joseph, D., Hemmens, V., Munns, C. (2012). Stability of Oral Cholecalciferol (vitamin D3) Liquid Formulations in Olive Oil. Journal of Pharmacy Practice and Research, 42(3), 213-217.
  • Ooi, H., Briody, J., McQuade, M., Munns, C. (2012). Zoledronic acid improves bone mineral density in paediatric spinal cord injury. Journal of Bone and Mineral Research, 27(7), 1536-1540. [More Information]
  • Rana, M., Munns, C., Selvadurai, H., Simonds, S., Cooper, P., Woodhead, H., Hameed, S., Verge, C., Lafferty, A., Crock, P., Craig, M. (2011). Increased detection of cystic-fibrosis-related diabetes in Australia. Archives of Disease in Childhood, 96(9), 823-826. [More Information]
  • Isaacs, D., Tobin, B., Hamblin, J., Slaytor, E., Donaghue, K., Munns, C., Kilham, H. (2011). Managing ethically questionable parental requests: Growth suppression and manipulation of puberty. Journal of Paediatrics and Child Health, 47(9), 581-584. [More Information]
  • Bridge, P., Pocock, N., Nguyen, T., Munns, C., Cowell, C., Forwood, N., Thompson, M. (2011). Validation of Longitudinal DXA Changes in Body Composition From Pre- to Mid-Adolescence Using MRI as Reference. Journal of Clinical Densitometry: Assessment of Skeletal Health, 14(3), 340-347. [More Information]
  • Sim, P., Johannesen, J., Briody, J., McQuade, M., Hsu, B., Bridge, C., Little, D., Cowell, C., Munns, C. (2011). Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2 years of treatment in children with secondary osteoporosis. Bone, 49(5), 939-943. [More Information]
  • Rana, M., Munns, C., Selvadurai, H., Donaghue, K., Craig, M. (2010). Cystic fibrosis-related diabetes in children-gaps in the evidence? Nature Reviews Endocrinology, 6(7), 371-378. [More Information]
  • Pacey, V., Nicholson, L., Adams, R., Munn, J., Munns, C. (2010). Generalized Joint Hypermobility and Risk of Lower Limb Joint Injury During Sport: A Systematic Review With Meta-Analysis. American Journal of Sports Medicine, 38(7), 1487-1497. [More Information]
  • Birke, O., Schindeler, A., Ramachandran, M., Cowell, C., Munns, C., Bellemore, M., Little, D. (2010). Preliminary experience with the combined use of recombinant bone morphogenetic protein and bisphosphonates in the treatment of congenital pseudarthrosis of the tibia. Journal of Children's Orthopaedics, 4(6), 507-517. [More Information]
  • David-Vizcarra, G., Briody, J., Ault, J., Fietz, M., Fletcher, J., Savarirayan, R., Wilson, M., McGill, J., Edwards, M., Munns, C., Sillence, D., et al (2010). The natural history and osteodystrophy of mucolipidosis types II and III. Journal of Paediatrics and Child Health, 46(6), 316-322. [More Information]
  • Simmons, P., Briody, J., McQuade, M., Munns, C. (2010). The successful use of pamidronate in an 11-year-old girl with complex regional pain syndrome: response to treatment demonstrated by serial peripheral quantitative computerised tomographic scans. Bone, 46(4), 885-888. [More Information]
  • Ramjan, K., Roscioli, T., Rutsch, F., Sillence, D., Munns, C. (2009). Generalized arterial calcification of infancy: treatment with bisphosphonates. Nature clinical practice: Endocrinology and metabolism, 5(3), 167-172. [More Information]
  • Cross, S., Dalla-Pozza, L., Munns, C. (2009). Hypercalcemia and osteoblastic lesions induced by 13-Cis-retinoic acid mimicking relapsed neuroblastoma. Pediatric Blood & Cancer, 53(4), 666-668. [More Information]
  • Bridge, P., Pocock, N., Nguyen, T., Munns, C., Cowell, C., Thompson, M. (2009). Prediction of appendicular skeletal and fat mass in children: excellent concordance of dual-energy X-ray absorptiometry and magnetic resonance imaging. Journal Of Pediatric Endocrinology and Metabolism, 22(9), 795-804. [More Information]
  • Rauch, F., Munns, C., Land, C., Cheung, M., Glorieux, F. (2009). Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study. Journal of Bone and Mineral Research, 24(7), 1282-1289. [More Information]
  • Nguyen, K., Briody, J., McQuade, M., Little, D., Cowell, C., Munns, C. (2009). Systemic effects of zoledronic acid in children with traumatic femoral head avascular necrosis and Legg-Calve-Perthes disease. Bone, 45(5), 898-902. [More Information]
  • Tofts, L., Elliott, E., Munns, C., Pacey, V., Sillence, D. (2009). The differential diagnosis of children with joint hypermobility: a review of the literature. Pediatric Rheumatology Online Journal, 7(1), 1-1-1-10. [More Information]
  • Benitez-Aguirre, P., Wood, N., Biesheuvel, C., Moreira, C., Munns, C. (2009). The natural history of vitamin D deficiency in African refugees living in Sydney. Medical Journal of Australia, 190(8), 426-428. [More Information]
  • Gleeson, H., Wiltshire, E., Briody, J., Hall, J., Chaitow, J., Sillence, D., Cowell, C., Munns, C. (2008). Childhood chronic recurrent multifocal osteomyelitis: pamidronate therapy decreases pain and improves vertebral shape. Journal of Rheumatology, 35(4), 707-712. [More Information]
  • Rauch, F., Plotkin, H., DiMeglio, L., Engelbert, R., Henderson, R., Munns, C., Wenkert, D., Zeitler, P. (2008). Fracture Prediction and the Definition of Osteoporosis in Children and Adolescents: The ISCD 2007 Pediatric Official Positions. Journal of Clinical Densitometry: Assessment of Skeletal Health, 11(1), 22-28. [More Information]
  • Liu, A., Briody, J., Munns, C., Waugh, M. (2008). Regional changes in bone mineral density following spinal cord injury in children. Developmental Neurorehabilitation, 11(1), 51-59. [More Information]
  • Munns, C., Rajab, M., Hong, J., Briody, J., Hoegler, W., McQuade, M., Little, D., Cowell, C. (2007). Acute phase response and mineral status following low dose intravenous zoledronic acid in children. Bone, 41, 366-370. [More Information]
  • Ramachandran, M., Ward, K., Brown, R., Munns, C., Cowell, C., Little, D. (2007). Intravenous bisphosphonate therapy for traumatic osteonecrosis of the femoral head in adolescents. Journal of Bone and Joint Surgery-American Volume, 89(8), 1727-1734. [More Information]
  • Bellemore, M., Munns, C. (2007). Osteogenesis Imperfecta. Locomotor System: Advances in Research, Diagnostics and Therapy, 14(3+4), 232-238.
  • Munns, C., Zacharin, M., Rodda, C., Batch, J., Morley, R., Cranswick, N., Craig, M., Cutfield, W., Hofman, P., Taylor, B., Burgner, D., Cowell, C., et al (2006). Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: a consensus statement. Medical Journal of Australia, 185(5), 268-272. [More Information]
  • Munns, C., Cowell, C. (2005). Prevention and treatment of osteoporosis in chronically ill children. Journal of Musculoskeletal and Neuronal Interactions, 5(3), 262-72. [More Information]

Conferences

  • Pacey, V., Tofts, L., Adams, R., Munns, C., Nicholson, L. (2013). A randomised controlled trial of two exercise programmes for children with joint hypermobility syndrome and knee pain. APA Conference 2013 'New Moves', Melbourne: Australian Physiotherapy Association.
  • Pacey, V., Tofts, L., Adams, R., Munns, C., Nicholson, L. (2013). The fatigue experience of children with joint hypermobility syndrome: a parent and child's perspective. APA Conference 2013 'New Moves', Melbourne: Australian Physiotherapy Association.
  • Pacey, V., Tofts, L., Adams, R., Nicholson, L., Munns, C. (2012). Exercise programmes for children with joint hypermobility syndrome and knee pain: a randomised controlled trial. Australian Rheumatology Association in conjunction with Rheumatology Health Professionals 53rd Annual Scientific Meeting Conference, Australia: Wiley-Blackwell Publishing Asia Pty Ltd.
  • Pacey, V., Nicholson, L., Adams, R., Munn, J., Munns, C. (2012). Generalised joint hypermobility and risk of lower limb joint injury during sport: a systematic review with meta-analysis. Australian Rheumatology Association in conjunction with Rheumatology Health Professionals 53rd Annual Scientific Meeting Conference, Australia: Wiley-Blackwell Publishing Asia Pty Ltd.

2016

  • Jefferson, A., Leonard, H., Siafarikas, A., Woodhead, H., Fyfe, S., Ward, L., Munns, C., Motil, K., Tarquinio, D., Shapiro, J., Ellaway, C., et al (2016). Clinical Guidelines for Management of Bone Health in Rett Syndrome Based on Expert Consensus and Available Evidence. PloS One, 11(2), 1-18. [More Information]
  • Munns, C., Shaw, N., Kiely, M., Specker, B., Thacher, T., Ozono, K., Michigami, T., Tiosano, D., Mughal, M., Makitie, O., et al (2016). Global Consensus Recommendations on Prevention and Management of Nutritional Rickets. Hormone Research in Paediatrics, 85(2), 83-106. [More Information]
  • Munns, C., Shaw, N., Kiely, M., Specker, B., Thacher, T., Osaka, K., Michigami, T., Tiosano, D., Mughal, M., Mäkitie, O., et al (2016). Global Consensus Recommendations on Prevention and Management of Nutritional Rickets. Journal of Clinical Endocrinology and Metabolism, 101(2), 394-415. [More Information]
  • Rushworth, L., Falhammar, H., Munns, C., Maguire, A., Torpy, D. (2016). Hospital Admission Patterns in Children with CAH: Admission Rates and Adrenal Crises Decline with Age. International Journal of Endocrinology, 2016 (Article number 5748264), 1-8. [More Information]
  • Padhye, B., Dalla-Pozza, L., Little, D., Munns, C. (2016). Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL). Cancer Medicine, 5(5), 960-967. [More Information]
  • Hsu, P., Ma, A., Barnes, E., Wilson, M., Hoefsloot, L., Rinne, T., Munns, C., Williams, G., Wong, M., Mehr, S. (2016). The Immune Phenotype of Patients with CHARGE Syndrome. The Journal of Allergy and Clinical Immunology: In Practice, 4(1), 96-103e.2. [More Information]
  • Bishop, N., Munns, C., Ozono, K. (2016). Transformative therapy in hypophosphatasia. Archives of Disease in Childhood, 101(6), 514-515. [More Information]

2015

  • Korula, S., Titmuss, A., Biggin, A., Munns, C. (2015). A Practical Approach to Children with Recurrent Fractures. Endocrine Development, 28, 210-225. [More Information]
  • Brookes, D., Briody, J., Munns, C., Davies, P., Hill, R. (2015). Cystic fibrosis-related bone disease in children: Examination of peripheral quantitative computed tomography (pQCT) data. Journal of Cystic Fibrosis, 14(5), 668-677. [More Information]
  • Munns, C., Fahiminiya, S., Poudel, N., Munteanu, M., Majewski, J., Sillence, D., Metcalf, J., Biggin, A., Glorieux, F., Fassier, F., et al (2015). Homozygosity for Frameshift Mutations in XYLT2 Result in a Spondylo-Ocular Syndrome with Bone Fragility, Cataracts, and Hearing Defects. American Journal of Human Genetics, 96(6), 971-978. [More Information]
  • Pacey, V., Adams, R., Tofts, L., Munns, C., Nicholson, L. (2015). Joint hypermobility syndrome subclassification in paediatrics: A factor analytic approach. Archives of Disease in Childhood, 100(1), 8-13. [More Information]
  • Pacey, V., Tofts, L., Adams, R., Munns, C., Nicholson, L. (2015). Quality of life prediction in children with joint hypermobility syndrome. Journal of Paediatrics and Child Health, 51(7), 689-695. [More Information]
  • Biggin, A., Zheng, L., Briody, J., Coorey, C., Munns, C. (2015). The long-term effects of switching from active intravenous bisphosphonate treatment to low-dose maintenance therapy in children with osteogenesis imperfecta. Hormone Research in Paediatrics, 83(3), 183-189. [More Information]

2014

  • Hsu, P., Ma, A., Wilson, M., Williams, G., Curotta, J., Munns, C., Mehr, S. (2014). CHARGE syndrome: A review. Journal of Paediatrics and Child Health, 50(7), 504-511. [More Information]
  • Brookes, D., Briody, J., Munns, C., Davies, P., Hill, R. (2014). Cystic fibrosis-related bone disease explored using a four step algorithm. Journal of Cystic Fibrosis, 14(1), 127-134. [More Information]
  • Bonnemann, C., Wang, C., Quijano-Roy, S., Deconinck, N., Bertini, E., Ferreiro, A., Muntoni, F., Sewry, C., Beroud, C., Mathews, K., et al (2014). Diagnostic approach to the congenital muscular dystrophies. Neuromuscular Disorders, 24(4), 289-311. [More Information]
  • Biggin, A., Briody, J., Ormshaw, E., Wong, K., Bennetts, B., Munns, C. (2014). Fracture during Intravenous Bisphosphonate Treatment in a Child with Osteogenesis Imperfecta: An Argument for a More Frequent, Low-Dose Treatment Regimen. Hormone Research in Paediatrics, 81(3), 204-210. [More Information]
  • Bishop, N., Arundel, P., Clark, E., Dimitri, P., Farr, J., Jones, G., Makitie, O., Munns, C., Shaw, N. (2014). Fracture Prediction and the Definition of Osteoporosis in Children and Adolescents: The ISCD 2013 Pediatric Official Positions. Journal of Clinical Densitometry: Assessment of Skeletal Health, 17(2), 275-280. [More Information]
  • Dasgupta, D., Wee, M., Reyes, M., Li, Y., Simm, P., Sharma, A., Schlingmann, K., Janner, M., Biggin, A., Lazier, J., Munns, C., et al (2014). Mutations in SLC34A3/NPT2c Are Associated with Kidney Stones and Nephrocalcinosis. Journal of the American Society of Nephrology, 25(10), 2366-2375. [More Information]
  • Biggin, A., Munns, C. (2014). Osteogenesis Imperfecta: Diagnosis and Treatment. Current Osteoporosis Reports, 12(3), 279-288. [More Information]
  • Pacey, V., Adams, R., Tofts, L., Munns, C., Nicholson, L. (2014). Proprioceptive acuity into knee hypermobile range in children with Joint Hypermobility Syndrome. Pediatric Rheumatology Online Journal, 12(1), 1-7. [More Information]
  • Nicholson, L., Pacey, V., Tofts, L., Munns, C., Adams, R. (2014). Signs and symptoms of foot and ankle dysfunction in children with joint hypermobility. Journal of Foot and Ankle Research, 7(Suppl 1).
  • Lazarus, S., McInerney-Leo, A., McKenzie, F., Baynam, G., Broley, S., Cavan, B., Munns, C., Pruijs, H., Sillence, D., Terhal, P., et al (2014). The IFITM5 mutation c.-14C > T results in an elongated transcript expressed in human bone; and causes varying phenotypic severity of osteogenesis imperfecta type V. BMC Musculoskeletal Disorders, 15(1), 1-6. [More Information]
  • Bhatt, R., Hibbert, S., Munns, C. (2014). The use of bisphosphonates in children: Review of the literature and guidelines for dental management. Australian Dental Journal, 59(1), 9-19. [More Information]
  • Bhatt, R., Hibbert, S., Munns, C. (2014). Use of bisphosphonates in children: authors' reply. Australian Dental Journal, 59(3), 405-406. [More Information]
  • Yap, C., Cheung, N., Gunton, J., Athayde, N., Munns, C., Duke, A., Mclean, M. (2014). Vitamin D Supplementation and the Effects on Glucose Metabolism During Pregnancy: A Randomized Controlled Trial. Diabetes Care, 37(7), 1837-1844. [More Information]

2013

  • Pacey, V., Tofts, L., Adams, R., Munns, C., Nicholson, L. (2013). A randomised controlled trial of two exercise programmes for children with joint hypermobility syndrome and knee pain. APA Conference 2013 'New Moves', Melbourne: Australian Physiotherapy Association.
  • Munns, C. (2013). Adolescent Bone Health. In Kate Steinbeck, Michael Kohn (Eds.), A Clinical Handbook in Adolescent Medicine: A Guide for Health Professionals Who Work with Adolescents and Young Adults, (pp. 479-490). Singapore: World Scientific Publishing.
  • Biggin, A., Briody, J., Ramjan, K., Middleton, A., Waugh, M., Munns, C. (2013). Evaluation of bone mineral density and morphology using pQCT in children after spinal cord injury. Developmental Neurorehabilitation, 16(6), 391-397. [More Information]
  • Pacey, V., Tofts, L., Adams, R., Munns, C., Nicholson, L. (2013). Exercise in children with joint hypermobility syndrome and knee pain: a randomised controlled trial comparing exercise into hypermobile versus neutral knee extension. Pediatric Rheumatology Online Journal, 11(1), 1-11. [More Information]
  • Alcausin, M., Briody, J., Pacey, V., Ault, J., McQuade, M., Bridge, C., Engelbert, R., Sillence, D., Munns, C. (2013). Intravenous Pamidronate Treatment in Children with Moderate-to-Severe Osteogenesis Imperfecta Started under Three Years of Age. Hormone Research in Paediatrics, 79(6), 333-340. [More Information]
  • Ooi, H., Briody, J., Biggin, A., Cowell, C., Munns, C. (2013). Intravenous Zoledronic Acid Given Every 6 Months in Childhood Osteoporosis. Hormone Research in Paediatrics, 80(3), 179-184. [More Information]
  • Bishop, N., Adami, S., Ahmed, S., Anton, J., Arundel, P., Burren, C., Devogelaer, J., Hangartner, T., Hosszu, E., Munns, C., et al (2013). Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial. The Lancet, 382(9902), 1424-1432. [More Information]
  • O'Keefe, K., Orr, R., Huang, P., Selvadurai, H., Cooper, P., Munns, C., Fiatarone Singh, M. (2013). The effect of whole body vibration exposure on muscle function in children with cystic fibrosis: a pilot efficacy trial. Journal of Clinical Medicine Research, 5(3), 205-216. [More Information]
  • Pacey, V., Tofts, L., Adams, R., Munns, C., Nicholson, L. (2013). The fatigue experience of children with joint hypermobility syndrome: a parent and child's perspective. APA Conference 2013 'New Moves', Melbourne: Australian Physiotherapy Association.
  • Rana, M., Munns, C., Selvadurai, H., Briody, J., Craig, M. (2013). The impact of dysglycaemia on bone mineral accrual in young people with cystic fibrosis. Clinical Endocrinology, 78(1), 36-42. [More Information]
  • Padhye, B., Dalla-Pozza, L., Little, D., Munns, C. (2013). Use of Zoledronic Acid for Treatment of Chemotherapy Related Osteonecrosis in Children and Adolescents: A Retrospective Analysis. Pediatric Blood & Cancer, 60(9), 1539-1545. [More Information]
  • Paxton, G., Teale, G., Nowson, C., Mason, R., McGrath, J., Thompson, M., Siafarikas, A., Rodda, C., Munns, C. (2013). Vitamin D and health in pregnancy, infants, children and adolescents in Australia and New Zealand: a position statement. Medical Journal of Australia, 198(3), 142-143. [More Information]

2012

  • Wang, C., Dowling, J., North, K., Schroth, M., Sejersen, T., Shapiro, F., Bellini, J., Weiss, H., Guillet, M., Amburgey, K., Clarke, N., Fitzgerald, D., Munns, C., Rose, K., et al (2012). Consensus statement on standard of care for congenital myopathies. Journal of Child Neurology, 27(3), 363-382. [More Information]
  • Pacey, V., Tofts, L., Adams, R., Nicholson, L., Munns, C. (2012). Exercise programmes for children with joint hypermobility syndrome and knee pain: a randomised controlled trial. Australian Rheumatology Association in conjunction with Rheumatology Health Professionals 53rd Annual Scientific Meeting Conference, Australia: Wiley-Blackwell Publishing Asia Pty Ltd.
  • Pacey, V., Nicholson, L., Adams, R., Munn, J., Munns, C. (2012). Generalised joint hypermobility and risk of lower limb joint injury during sport: a systematic review with meta-analysis. Australian Rheumatology Association in conjunction with Rheumatology Health Professionals 53rd Annual Scientific Meeting Conference, Australia: Wiley-Blackwell Publishing Asia Pty Ltd.
  • Munns, C., Simm, P., Rodda, C., Garnett, S., Zacharin, M., Ward, L., Geddes, J., Cherain, S., Zurynski, Y., Cowell, C. (2012). Incidence of vitamin D deficiency rickets among Australian children: an Australian Paediatric Surveillance Unit study. Medical Journal of Australia, 196(7), 466-468. [More Information]
  • Cho, Y., Tchan, M., Roy, B., Halliday, R., Wilson, M., Dutt, S., Siew, S., Munns, C., Howard, N. (2012). Recombinant Parathyroid Hormone Therapy for Severe Neonatal Hypoparathyroidism. The Journal of Pediatrics, 160(2), 345-348. [More Information]
  • Joseph, D., Hemmens, V., Munns, C. (2012). Stability of Oral Cholecalciferol (vitamin D3) Liquid Formulations in Olive Oil. Journal of Pharmacy Practice and Research, 42(3), 213-217.
  • Ooi, H., Briody, J., McQuade, M., Munns, C. (2012). Zoledronic acid improves bone mineral density in paediatric spinal cord injury. Journal of Bone and Mineral Research, 27(7), 1536-1540. [More Information]

2011

  • Rana, M., Munns, C., Selvadurai, H., Simonds, S., Cooper, P., Woodhead, H., Hameed, S., Verge, C., Lafferty, A., Crock, P., Craig, M. (2011). Increased detection of cystic-fibrosis-related diabetes in Australia. Archives of Disease in Childhood, 96(9), 823-826. [More Information]
  • Isaacs, D., Tobin, B., Hamblin, J., Slaytor, E., Donaghue, K., Munns, C., Kilham, H. (2011). Managing ethically questionable parental requests: Growth suppression and manipulation of puberty. Journal of Paediatrics and Child Health, 47(9), 581-584. [More Information]
  • Bridge, P., Pocock, N., Nguyen, T., Munns, C., Cowell, C., Forwood, N., Thompson, M. (2011). Validation of Longitudinal DXA Changes in Body Composition From Pre- to Mid-Adolescence Using MRI as Reference. Journal of Clinical Densitometry: Assessment of Skeletal Health, 14(3), 340-347. [More Information]
  • Sim, P., Johannesen, J., Briody, J., McQuade, M., Hsu, B., Bridge, C., Little, D., Cowell, C., Munns, C. (2011). Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2 years of treatment in children with secondary osteoporosis. Bone, 49(5), 939-943. [More Information]

2010

  • Rana, M., Munns, C., Selvadurai, H., Donaghue, K., Craig, M. (2010). Cystic fibrosis-related diabetes in children-gaps in the evidence? Nature Reviews Endocrinology, 6(7), 371-378. [More Information]
  • Pacey, V., Nicholson, L., Adams, R., Munn, J., Munns, C. (2010). Generalized Joint Hypermobility and Risk of Lower Limb Joint Injury During Sport: A Systematic Review With Meta-Analysis. American Journal of Sports Medicine, 38(7), 1487-1497. [More Information]
  • Birke, O., Schindeler, A., Ramachandran, M., Cowell, C., Munns, C., Bellemore, M., Little, D. (2010). Preliminary experience with the combined use of recombinant bone morphogenetic protein and bisphosphonates in the treatment of congenital pseudarthrosis of the tibia. Journal of Children's Orthopaedics, 4(6), 507-517. [More Information]
  • David-Vizcarra, G., Briody, J., Ault, J., Fietz, M., Fletcher, J., Savarirayan, R., Wilson, M., McGill, J., Edwards, M., Munns, C., Sillence, D., et al (2010). The natural history and osteodystrophy of mucolipidosis types II and III. Journal of Paediatrics and Child Health, 46(6), 316-322. [More Information]
  • Simmons, P., Briody, J., McQuade, M., Munns, C. (2010). The successful use of pamidronate in an 11-year-old girl with complex regional pain syndrome: response to treatment demonstrated by serial peripheral quantitative computerised tomographic scans. Bone, 46(4), 885-888. [More Information]

2009

  • Ramjan, K., Roscioli, T., Rutsch, F., Sillence, D., Munns, C. (2009). Generalized arterial calcification of infancy: treatment with bisphosphonates. Nature clinical practice: Endocrinology and metabolism, 5(3), 167-172. [More Information]
  • Cross, S., Dalla-Pozza, L., Munns, C. (2009). Hypercalcemia and osteoblastic lesions induced by 13-Cis-retinoic acid mimicking relapsed neuroblastoma. Pediatric Blood & Cancer, 53(4), 666-668. [More Information]
  • Bridge, P., Pocock, N., Nguyen, T., Munns, C., Cowell, C., Thompson, M. (2009). Prediction of appendicular skeletal and fat mass in children: excellent concordance of dual-energy X-ray absorptiometry and magnetic resonance imaging. Journal Of Pediatric Endocrinology and Metabolism, 22(9), 795-804. [More Information]
  • Rauch, F., Munns, C., Land, C., Cheung, M., Glorieux, F. (2009). Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study. Journal of Bone and Mineral Research, 24(7), 1282-1289. [More Information]
  • Nguyen, K., Briody, J., McQuade, M., Little, D., Cowell, C., Munns, C. (2009). Systemic effects of zoledronic acid in children with traumatic femoral head avascular necrosis and Legg-Calve-Perthes disease. Bone, 45(5), 898-902. [More Information]
  • Tofts, L., Elliott, E., Munns, C., Pacey, V., Sillence, D. (2009). The differential diagnosis of children with joint hypermobility: a review of the literature. Pediatric Rheumatology Online Journal, 7(1), 1-1-1-10. [More Information]
  • Benitez-Aguirre, P., Wood, N., Biesheuvel, C., Moreira, C., Munns, C. (2009). The natural history of vitamin D deficiency in African refugees living in Sydney. Medical Journal of Australia, 190(8), 426-428. [More Information]

2008

  • Gleeson, H., Wiltshire, E., Briody, J., Hall, J., Chaitow, J., Sillence, D., Cowell, C., Munns, C. (2008). Childhood chronic recurrent multifocal osteomyelitis: pamidronate therapy decreases pain and improves vertebral shape. Journal of Rheumatology, 35(4), 707-712. [More Information]
  • Rauch, F., Plotkin, H., DiMeglio, L., Engelbert, R., Henderson, R., Munns, C., Wenkert, D., Zeitler, P. (2008). Fracture Prediction and the Definition of Osteoporosis in Children and Adolescents: The ISCD 2007 Pediatric Official Positions. Journal of Clinical Densitometry: Assessment of Skeletal Health, 11(1), 22-28. [More Information]
  • Liu, A., Briody, J., Munns, C., Waugh, M. (2008). Regional changes in bone mineral density following spinal cord injury in children. Developmental Neurorehabilitation, 11(1), 51-59. [More Information]

2007

  • Munns, C., Rajab, M., Hong, J., Briody, J., Hoegler, W., McQuade, M., Little, D., Cowell, C. (2007). Acute phase response and mineral status following low dose intravenous zoledronic acid in children. Bone, 41, 366-370. [More Information]
  • Ramachandran, M., Ward, K., Brown, R., Munns, C., Cowell, C., Little, D. (2007). Intravenous bisphosphonate therapy for traumatic osteonecrosis of the femoral head in adolescents. Journal of Bone and Joint Surgery-American Volume, 89(8), 1727-1734. [More Information]
  • Bellemore, M., Munns, C. (2007). Osteogenesis Imperfecta. Locomotor System: Advances in Research, Diagnostics and Therapy, 14(3+4), 232-238.

2006

  • Munns, C., Zacharin, M., Rodda, C., Batch, J., Morley, R., Cranswick, N., Craig, M., Cutfield, W., Hofman, P., Taylor, B., Burgner, D., Cowell, C., et al (2006). Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: a consensus statement. Medical Journal of Australia, 185(5), 268-272. [More Information]

2005

  • Munns, C., Cowell, C. (2005). Prevention and treatment of osteoporosis in chronically ill children. Journal of Musculoskeletal and Neuronal Interactions, 5(3), 262-72. [More Information]

To update your profile click here. For support on your academic profile contact .